Lakeland Medical Center

Lakeland Medical Center is a comprehensive healthcare facility located in St. Joseph, Michigan, and serves as a primary hospital for the Corewell Health South system (formerly Spectrum Health Lakeland). Founded in 1899, the center has established itself as a regional leader in medical services, including advanced oncology, cardiology, and behavioral health. It is highly active in clinical research, particularly through the Marie Yeager Cancer Center, where it serves as a clinical trial site for numerous Phase II and Phase III studies in collaboration with national research networks such as the National Cancer Institute (NCI). The center's research portfolio includes innovative treatments for multiple myeloma, rare tumors, and various solid tumors, utilizing therapeutic modalities like monoclonal antibodies and targeted small molecules. Following its 2018 acquisition by Spectrum Health and the subsequent formation of Corewell Health, Lakeland Medical Center continues to integrate cutting-edge clinical research with community-based patient care.